This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Exiqon A/s. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Torsten Bryld: Innovator in Oligomeric Compounds
Introduction
Torsten Bryld is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of biochemistry, particularly in the development of novel modified oligomeric compounds. His work focuses on enhancing the cellular uptake of these compounds, which has important implications for medical research and treatment.
Latest Patents
Torsten Bryld holds a patent for "Mediated cellular delivery of LNA oligonucleotides." This invention relates to innovative methods of making and using modified oligomeric compounds. The patent also details methods for enhancing the cellular uptake of these compounds by conjugating a metal chelator to them. He has 1 patent to his name, showcasing his expertise in this specialized area.
Career Highlights
Torsten Bryld is associated with Exiqon A/S, a company known for its advancements in molecular biology and diagnostics. His role at Exiqon has allowed him to work on cutting-edge research and development projects that push the boundaries of current scientific understanding.
Collaborations
Throughout his career, Torsten has collaborated with esteemed colleagues, including Soeren Vestergaard Rasmussen and Soeren Moeller. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Torsten Bryld's contributions to the field of oligomeric compounds and his innovative patent demonstrate his commitment to advancing scientific knowledge. His work continues to influence the landscape of biochemistry and molecular biology.